NCT05611775 Adult Spinal Deformity Surgery Real-World Functional Activity
| NCT ID | NCT05611775 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Degenerative Thoracolumbar Deformity |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2023-06-16 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2023-06-16 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to measure functional activity and stability in spinal deformity patients utilizing motion analysis testing and accelerometers.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of degenerative thoracolumbar deformity * Deformity correction surgery scheduled with either Dr. Elder or Dr. Fogelson, minimum 4-level fusion with fixation to the pelvis. Exclusion Criteria: ° Unable to return to Mayo Clinic for follow-up evaluation
Contact & Investigator
Benjamin Elder, MD, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT05611775 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Degenerative Thoracolumbar Deformity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05611775 currently recruiting?
Yes, NCT05611775 is actively recruiting participants. Contact the research team at Ranfranz.Rebecca@mayo.edu for enrollment information.
Where is the NCT05611775 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT05611775 clinical trial?
NCT05611775 is sponsored by Mayo Clinic. The principal investigator is Benjamin Elder, MD, PhD at Mayo Clinic. The trial plans to enroll 50 participants.